Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

23 Nov 2021 Evaluate

Alembic Pharmaceuticals has informed that it enclosed a press release regarding receipt of US Food & Drug Administration (USFDA) Tentative Approval for Dabigatran Etexilate Capsules, 150 mg.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..